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INTRODUCTION
It is known that in patients with chronic 
obstructive pulmonary disease (COPD), right heart 
function is impaired (6) and severity of pulmonary 
hypertension (PH) relates to prognosis (13). Long-term 
oxygen therapy (14) and potentiating medication (5) 
may improve the prognosis by reducing pulmonary 
hypertension. This determines the necessity for non-
invasive evaluation of pulmonary hypertension (1) 
and associated disorders in right ventricular (RV) 
function. The non-invasive estimation of pulmonary 
artery (PA) pressures is accompanied by a series of 
ABSTRACT
PURPOSE: The purpose of this study is to evaluate by subxiphoid echocardiography the sensitivity and spec-
ificity of various echocardiographic parameters for early diagnosis and survival of patients with chronic ob-
structive pulmonary disease (COPD).
MATERIAL AND METHODS: Subxiphoid echocardiography was performed in 75 COPD patients to eval-
uate inferior vena cava dimension (IVCD), its collapsibility index (CI), end-diastolic right ventricular di-
mension (EDRVD), end-diastolic right ventricular thickness (EDRVT) (M-mode), right atrial area (RAA), 
right ventricular areas and right ventricular area shortening fraction. Results were compared to those of 
30 healthy controls. Patients in sinus rhythm were divided in two according to there NYHA class (I+II and 
III+IV) an in three according to there acid-base blood gases status.
RESULTS: All the indexes were equally and significantly changed in the patients with RVH/PH and those 
with COPD and atrial fibrillation (AF) when compared to controls. COPD patients with neither ECG crite-
ria for RV hypertrophy (RVH), nor x-ray evidence of pulmonary hypertension (PH) presented with signifi-
cantly greater EDRVA and RAA and normal IVC/CI. In both cases, according to cardiac and respiratory se-
verity status subdivision, significant changes in any indexes with worsening of cardiac and respiratory fail-
ure were observed. Best sensitivity, specificity and predictive accuracy for early diagnosis were established 
for IVCD/CI and EDRVT. During the two-year study period, seven (9%) patients died in end stage respirato-
ry and heart failure because of considerably reduced right heart performance. 
CONCLUSION: Subxiphoid echocardiography may be used for early detection of cor pulmonale, evaluation 
of right heart dysfunction and prognosis in COPD patients 
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pitfalls. Subxiphoid approach of two-dimensional 
echocardiography is frequently used, however, its 
capacities in COPD patients are not completely 
explored yet (1,2,9,11,15).
MATERIAL AND METHODS 
In the present study, inclusion criteria 
were history of bronchitis, emphysema on x-ray, 
physical findings of crackles and wheezing, acid-
base status and spirometry (4). Exclusion criteria 
were hypertension, myocardial infarction, angina 
pectoris, acquired and congenital cardiac defects. 
Hypertension was allowed in the group of patients 
with COPD and atrial fibrillation (AF). 
Using two-dimensional and M-mode subxiphoid 
echocardiography, the following parameters were 
studied in 75 COPD patients: dimensions of inferior 
vena cava (IVC) and percentage of inspiratory 
collapse-inspiratory collapsibility index (ICI ), end-
diastolic thickness of the right ventricular wall 
(EDRVWT) by two-dimensional directed M-mode 
echocardiography, end-diastolic inflow diameter of 
the right ventricle (RV) at the level of the tricuspid 
valve (EDDRV), right atrial area (RAA) and RV 
end-systolic and end-diastolic areas (ESRVA and 
EDRVAd), and RV area (RVA) change. All the indices 
were corrected for body surface area (BSA) (Table 1).
After exclusion of AF patients, COPD ones in 
sinus rhythm were divided in three ways depending 
on:
i) the presence or absence of pulmonary 
hypertension and/or RV hypertrophy by x-ray 
criteria or ECG (8,16);
ii) right heart failure of NYHA I-II class, i.e. no 
episodes of peripheral edema and NYHA III-IV class 
with one or more episodes of peripheral edema, and
iii) the severity of respiratory failure of grade 
0-I with or without hypoxemia at rest, of grade II 
with presence of hypercapnia, and of grade III with 
persistent decompensated acidosis despite 7-14 days 
of standard hospital treatment. 
Results were compared to those of 30 healthy 
subjects. ANOVA and statistical indices such as 
sensitivity, specificity and predictive accuracy were 
used (Table 2).
RESULTS 
Subxiphoid approach proved successful 
for visualization of IVC in 95%, - for EDRVWT 
measurement in 87% and for two-dimensional 
echocardiography measurements in 69% of the cases. 
Demographic and respiratory status of the 
patients and controls was shown on Table 3. Any 
ultrasound parameters in COPD patients were 
significantly changed compared to healthy controls. 
The same was true for COPD patients with AF 
whose indices were equally changed from the control 
group and did not differ from the patients in sinus 
rhythm. The parameters of the patients without PH 
Echocardiographic parameters Measurements
IVC in mm
Largest diameter after IVC ‘A’ wave at normal expiration and smallest diam-
eter at end-expiration by 2-D oriented M-mode
Collapsibility index (CI) in % (Expiratory diameter-inspiratory diameter):expiratory diameter x 100
EDRVWT in mm Subxiphoid 2-D oriented M-mode of EDRVWT
EDRVD in mm Subxiphoid 4-chamber 2-D echocardiography of inflow tract EDRVD
RAA in cm2 Subxiphoid  4-chamber  2-D echocardiography of end-systolic area  
EDRVA in cm2
Subxiphoid 4-chamber 2-D echocardiography of end-diastolic area at slight 
held inspiration
ESRVA in cm2
Subxiphoid 4-chamber  2-D echocardiography of end-systolic area at slight 
held inspiration
RVAFS in % (EDRVA-ESRVA):EDRVA x 100 
Table 1. Echocardiographic parameter definitions
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were also statistically significantly different from 
those of healthy controls except for IVC and RV area 
fractional shortening. The characteristics of these 
patients differed from those of the patients with 
PH except RVA fractional shortening (RVAFS), too. 
Statistically significant changes were found out for 
any parameters with advancement of cardiac and 
respiratory failure. During the two-year study period, 
seven (9%) patients died in end stage respiratory and 
heart failure because of considerably reduced right 
heart performance (Table 4 and Table 5).
Normal values of various echocardiographic 
indices were estimated and upper normal reference 
limits were used for calculating the sensitivity and 
specificity. Using normal reference limits from 
healthy volunteers, at least 50% of COPD patients 
without PH presented with altered parameters, 
including the patients with no hypoxemia at rest. 
At specificity and predictive accuracy of 100%, 
sensitivity for PH group varied from 71% to 93% 
for various echocardiographic parameters, the 
highest being for EDRVWT and IVC/IC. RVAFS was 
characterized by exceptionally low sensitivity in all 
the groups (Table 6).
DISCUSSION 
Right-heart echocardiagraphic subxiphoid 
parameters distinguish highly significantly the 
healthy subjects from COPD patients and this 
has already been observed in several studies of 
lung diseases, too. Subxiphoid echocardiography 
correlates both with radionuclide angiography and 
magnetic resonance imaging (10,11). 
Doppler studies, on the other hand, are deemed 
suitable for screening purposes, however, they lack 
accuracy (12). Doppler method of formula estimation 
of PA pressure using the velocity of tricuspid 
regurgitation in pulmonary diseases is considered 
the most convenient one (3).
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Table 2. COPD patients’ distribution according to cardiac 
and pulmonary status and evidence of PH













































Table 3. Demographic and respiratory data of COPD patients and controls
m - males; f - females; * - p < 0,001; NS - not significant
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RV dimension below the level of the tricuspid 
valve, tricuspid annulus dimension and RV free wall 
differentiate COPD patients from healthy controls 
and correlate with PA pressures (15). Mean PA 
pressure at rest and during exercise correlates with 
RV diameters and areas in end-systole and end-










































































































































































































































































































Table 5. Echocardiographic results in COPD patients according to cardiac and respiratory status
* - p < 0,001;  - p < 0,01; • - p < 0,02; ∆ - p < 0,05; NS - not significant
Table 4. Echocardiographic results in COPD patients and controls
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Controlled AF does not change statistically 
these parameters in comparison with PH patients. 
Evolution of chronic cardiac and respiratory 
failure significantly worsens all the parameters of 
right heart function. Normal values of subxiphoid 
echocardiographic indices of the group of healthy 
volunteers correspond to those reported in the 
literature available. At 100% specificity, all the 
indicators possess high sensitivity in PH patients 
with highest EDRVWT and IVC/IC rates. This can be 
used for early diagnosis of cor pulmonale in chronic 
respiratory disease. Subxiphoid echocardiography 
enables an improved recognition of cor pulmonale in 
severe COPD (7).
Echocardiographic examination has the 
potential to distinguish patients with and without PH 
on x-ray and RV hypertrophy on ECG. These indices 
possess certain predictive value in COPD patients 
and worsen with advancement of cardiac functional 
class and severity of respiratory failure. COPD 
patient’s survival is shortened above certain levels 
of deterioration of right heart function evaluated by 
echocardiography. 
CONCLUSIONS
1. Subxiphoid M-mode and two-dimensional 
echocardiographic parameters in non-
catheterized COPD patients separate them quite 
accurately from healthy subjects in everyday 
clinical practice. 
2. IVC diameter, its inspiratory collapse and 
RVWT are of highest sensitivity, specificity and 
predictive accuracy for early diagnosis of cor 
pulmonale.
3. The presence of RVH/PH (on ECG and x-
ray), hypercapnia and overt cardiac failure 
significantly change any echocardiographic 
parameters from the subxiphoid view. 
4. These parameters are changed in at least 50% 
of COPD patients without RVH/PH studied 
by both M-mode and two-dimensional 
echocardiography as IVCD/CI is most sensitive.
5. RVAFS is the least sensitive parameter.
6. Controlled AF in COPD patients seems not to 


















upper normal limit for 
healthy controls
8,7 38 5,0 38 8,4 8,2 5,3 33
specificity and predic-
tive accuracy
100 100 100 100 100 100 100 100
sensitivity 70 74
88
93 78 75 71 71 46
percentage of abnor-




50 50 50 50 50 33




84 67 67 67 62 42
sensitivity for COPD 
NYHA III+IV class 
86 86
100





Table 6. Statistical parameters in COPD patients
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7. Subxiphoid echocardiography might have 
certain prognostic value concerning COPD 
patient’s survival.   
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